Grassley to hold drug pricing hearing

Grassley to hold drug pricing hearing
© Stefani Reynolds

The Senate Finance Committee's first hearing of the year will focus on prescription drug prices, panel chairman Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleyTrump to sign USMCA next Wednesday Trump administration releases rule to restrict 'birth tourism' On The Money — Presented by Wells Fargo — Grassley signs USMCA, sending it to Trump's desk | Union membership falls to record low | Manufacturers want Trump tax provision made permanent | Warren presses banks on climate plans MORE (R-Iowa) announced Tuesday.

The Jan. 29 hearing "will be the first in a series of hearings scrutinizing prescription drug pricing and considering policy and oversight solutions to lower costs for American patients," Grassley said in a statement Tuesday.

"We already know what the problem is. It’s time to look at bipartisan solutions and work to turn them into law,” he added.

The Senate hearing will be the same day the Democratic-led House Oversight and Reform Committee holds the first of its own drug pricing hearings.

ADVERTISEMENT

The two hearings on the same day shows the bipartisan nature of the concern over rising drug prices.

Grassley and House Oversight and Reform Committee Chairman Elijah CummingsElijah Eugene CummingsBaltimore unveils plaques for courthouse to be named after Elijah Cummings GOP leaders encourage retiring lawmakers to give up committee posts Pelosi taps Virginia Democrat for key post on economic panel MORE (D-Md.) have made rising drug prices a central concern.

Grassley is largely seen as a dogged investigator who backs free-market principles, and is not seen as an ally of the pharmaceutical industry.

He is also willing to work with Democrats. In September he teamed up with Sen. Dick DurbinRichard (Dick) Joseph DurbinTensions between McConnell and Schumer run high as trial gains momentum Nadler gets under GOP's skin Restlessness, light rule-breaking and milk spotted on Senate floor as impeachment trial rolls on MORE (D-Ill.) to legislate that television advertisements for drugs be accompanied by price disclosures. The measure was ultimately blocked by House Republicans.

Earlier this month, Grassley laid out his priorities for drug pricing action, including legislation with Sen. Amy KlobucharAmy Jean KlobucharHarris weighing Biden endorsement: report Biden leads Democratic primary field nationally: poll CNN cancels next week's Iowa town halls MORE (D-Minn.) that would allow patients to import prescription drugs from Canada.

He has also expressed support for much of President TrumpDonald John TrumpSchiff pleads to Senate GOP: 'Right matters. And the truth matters.' Anita Hill to Iowa crowd: 'Statute of limitations' for Biden apology is 'up' Sen. Van Hollen releases documents from GAO investigation MORE's drug pricing agenda.